Advertisement

Comparative Role of Matrixins in Diagnostics of Parotid Gland Tumors

  • E. V. Kochurova
Article
  • 3 Downloads

The benign and malignant neoplasms in parotid gland have similar clinical presentations despite different tumor growth rates. The study compared the clinical and morphological data as well as the results of ELISA for MMP-2, MMP-8, MMP-9, TIMP-1, and TIMP-2 in salivary fluid yielded during primary examination of the patients with pleomorphic adenoma and adenocarcinoma of parotid gland. The examined biomarkers detected in salivary fluid in patients with various cancer types differed significantly (p≤0.05). The correlations between clinical identification of adenoma or adenocarcinoma, on the one hand, and the levels of MMP-8, TIMP-1, and TIMP-2, on the other hand, makes it possible to use the latter as biomarkers for early detection and comprehensive noninvasive differential diagnostics of these neoplasms.

Key Words

parotid gland saliva neoplasm adenoma adenocarcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR, Kamal MA, Nikolenko VN, Zamyatnin AA Jr, Benberin VV, Bachurin SO. Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of alzheimer disease. Curr. Med. Chem. 2014;21(19):2208-2217.CrossRefGoogle Scholar
  2. 2.
    Bradley P. General epidemiology and statistics in a defined UK population. Controversies in the Management of Salivary Gland Disease. McGurk M, Renehan A, eds. Oxford, 2001. P. 3-23.Google Scholar
  3. 3.
    Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 1999;284:808-812.CrossRefGoogle Scholar
  4. 4.
    Comis R. The ECOG Performance Status s in the public domain therefore available for public use. Eastern Cooperative Oncology Group. 2013. URL: http://ecog-acrin.org/resources/ecog-performance-status.
  5. 5.
    Couch Y, Trofimov A, Markova N, Nikolenko V, Steinbusch HW, Chekhonin V, Schroeter C, Lesch KP, Anthony DC, Strekalova T. Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice. J. Neuroinflammation. 2016;13(1):108. doi:  https://doi.org/10.1186/s12974-016-0572-0. CrossRefGoogle Scholar
  6. 6.
    Dzhimak SS, Basov AA, Baryshev MG. Content of deuterium in biological fluids and organs: influence of deuterium depleted water on D/H gradient and the process of adaptation. Dokl. Biochem. and Biophys. 2015;465:370-373.CrossRefGoogle Scholar
  7. 7.
    Golovastova MO, Tsoy LV, Bocharnikova AV, Korolev DO, Gancharova OS, Alekseeva EA, Kuznetsova EB, Savvateeva LV, Skorikova EE, Strelnikov VV, Varshavsky VA, Vinarov AZ, Nikolenko VN, Glybochko PV, Zernii EY, Zamyatnin AA Jr, Bazhin AV, Philippov PP. The cancer-retina antigen recoverin as a potential biomarker for renal tumors. Tumor Biol. 2016;37(7):9899-9907.CrossRefGoogle Scholar
  8. 8.
    Kochurova EV, Nikolenko VN. Estimation of expression of oral fluid biomarkers in the diagnosis of pretumor diseases of oral mucosa. Bull. Exp. Biol. Med. 2017;163(1):87-91.CrossRefGoogle Scholar
  9. 9.
    Kochurova EV, Nikolenko VN. Matrixins in the salivary fluid of patients with tumors of the maxillofacial region during orthopedic rehabilitation with different prosthetic structures. Bull. Exp. Biol. Med. 2017;163(5):663-666.CrossRefGoogle Scholar
  10. 10.
    McGurk М. Benign parotid tumours. BMJ. 2004;329:1299-1300.CrossRefGoogle Scholar
  11. 11.
    Nikolenko VN, Kalmin OV. Method and device for the removal of samples of organs and tissues for histological investigation. Neurosci. Behav. Physiol. 1996;26(3):234-236.CrossRefGoogle Scholar
  12. 12.
    Nikolenko VN, Kozlov SV, Kochurova EV. The effect of risk factors for a malignant neoplasm in the maxillofacial region on the expression of matrix metalloproteinases and their tissue inhibitors in elderly and old patients. Adv. Gerontol. 2015;5(1):50-53.CrossRefGoogle Scholar
  13. 13.
    Pitiyage GN, Lim KP, Gemenitzidis E, Teh MT, Waseem A, Prime SS, Tilakaratne WM, Fortune F, Parkinson EK. Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing. J. Oral Pathol. Med. 2012;41(6):454-462.CrossRefGoogle Scholar
  14. 14.
    Tilakaratne WM, Ekanayaka RP, Warnakulasuriya S. Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016;122(2):178-191.CrossRefGoogle Scholar
  15. 15.
    TNM Atlas: Illustrated Guide to the TNM Classification of Malignant Tumours. Wittekind Ch, Asamura H, Sobin LH, eds. Blackwell, 2014.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.I. M. Sechenov First Moscow State Medical University (Sechenov University)Ministry of Health of the Russian FederationMoscowRussia

Personalised recommendations